Corix Bioscience, Inc.
company.status.inactiveCIK 1433821fmd_1AXENKARCJTC2JD1M9QX5S24RJFinance, Insurance and Real Estate · Operators of Nonresidential BuildingsTemplate: Real estate
Coverage: Feb 01, 2007 to Sep 30, 2017, 34 periods
Latest annual · FY2016
Millions- Total revenues
- 1
- Operating income
- (3)
- Net income
- (4)
- Free cash flow
- 2
Key stats
Open AnalysisCompound annual growth
- Revenue, 3 yearsFY2014 to FY2016
- +33.6%
- Revenue, 5 yearsFY2013 to FY2016
- n/m
- Net income, 5 yearsFY2013 to FY2016
- n/m
Corix Bioscience, Inc. financials: quick answers
Annual figures as filed with the SEC. Each number links to the filing it came from and to its proof.
| Metric | FY2016 | FY2015 | Change | Source |
|---|---|---|---|---|
| Revenue | $693,621 | $482,426 | +43.8% | 10-K 2017-04-10 · proof |
| Net income | -$4.4 million | -$2.8 million | 10-K 2017-04-10 · proof | |
| Cash from operating activities | $1.8 million | -$2.5 million | 10-K 2017-04-10 · proof | |
| Free cash flow | $1.8 million | -$2.5 million | 10-K 2017-04-10 · proof | |
| Total assets | $11.4 million | $9.4 million | +20.7% | 10-K 2017-04-10 · proof |
| Total liabilities | $5.8 million | $4.4 million | +30.6% | 10-K 2017-04-10 · proof |
| Cash and cash equivalents | $2,151 | $199,570 | -98.9% | 10-K 2017-04-10 · proof |
- What was Corix Bioscience, Inc.'s revenue in fiscal 2016?
- Corix Bioscience, Inc. reported revenue of $693,621 for fiscal 2016 (the year ended Dec 31, 2016), against $482,426 the year before (+43.8%). Source: the 10-K filed with the SEC on Apr 10, 2017. SEC
- What was Corix Bioscience, Inc.'s net income in fiscal 2016?
- Corix Bioscience, Inc. reported net income of -$4.4 million for fiscal 2016 (the year ended Dec 31, 2016), against -$2.8 million the year before. Source: the 10-K filed with the SEC on Apr 10, 2017. SEC
- What was Corix Bioscience, Inc.'s cash from operating activities in fiscal 2016?
- Corix Bioscience, Inc. reported cash from operating activities of $1.8 million for fiscal 2016 (the year ended Dec 31, 2016), against -$2.5 million the year before. Source: the 10-K filed with the SEC on Apr 10, 2017. SEC
- What was Corix Bioscience, Inc.'s free cash flow in fiscal 2016?
- Corix Bioscience, Inc. reported free cash flow of $1.8 million for fiscal 2016 (the year ended Dec 31, 2016), against -$2.5 million the year before. Source: the 10-K filed with the SEC on Apr 10, 2017. SEC
- What are Corix Bioscience, Inc.'s total assets?
- As of Dec 31, 2016, Corix Bioscience, Inc. reported total assets of $11.4 million, against $9.4 million a year earlier (+20.7%). Source: the 10-K filed with the SEC on Apr 10, 2017. SEC
- What are Corix Bioscience, Inc.'s total liabilities?
- As of Dec 31, 2016, Corix Bioscience, Inc. reported total liabilities of $5.8 million, against $4.4 million a year earlier (+30.6%). Source: the 10-K filed with the SEC on Apr 10, 2017. SEC
- What are Corix Bioscience, Inc.'s cash and cash equivalents?
- As of Dec 31, 2016, Corix Bioscience, Inc. reported cash and cash equivalents of $2,151, against $199,570 a year earlier (-98.9%). Source: the 10-K filed with the SEC on Apr 10, 2017. SEC
Read from the FinancialMD API on Nov 13, 2026. Values change only when a new filing is made; see the Financials tab for every period and as-of replay.
The same numbers for an agent, with proof on every value:
curl "https://api.financial.md/v1/company/financials/income_statement/standardized?company=cik:1433821&period_type=annual&limit=5"Information only, not investment advice.